Comparative Evaluation of Bromelain-Quercetin Gel With Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing In Stage I /II and Grade B Periodontitis - Randomized Control Clinical Trail
1 other identifier
interventional
30
1 country
1
Brief Summary
Comparative Evaluation of Bromelain-Quercetin Gel With Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing In Stage I /II and Grade B Periodontitis - Randomized Control Clinical Trail
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_1
Started Jan 2024
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 5, 2024
CompletedFirst Submitted
Initial submission to the registry
January 9, 2025
CompletedFirst Posted
Study publicly available on registry
January 15, 2025
CompletedJanuary 15, 2025
January 1, 2025
7 months
January 9, 2025
January 9, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
PROBING POCKET DEPTH
measured using a UNC-15 probe (university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA
21DAYS
CLINICAL ATTACHMENT LEVEL
(university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA)
21DAYS
Secondary Outcomes (3)
Plaque Index
21DAYS
Gingival index
21DAYS
Modified Sulcus Bleeding Index
21days
Study Arms (3)
Group-1-SRP alone
ACTIVE COMPARATORcontrol group is treated with SRP alone
Group-2-2%bromelain-quercetin gel
EXPERIMENTALtest group treated with 2%bromelain-quercetin gel
Group-3-0.2% chlorhexidine gel
ACTIVE COMPARATORtest group treated with chlorhexidine gel
Interventions
bromelain-quercetin gel is prepared from capsules in laboratory
Eligibility Criteria
You may qualify if:
- Patient with have chronic periodontitis in the age group between 30-50 years.
- Patients having ≥20 teeth.
- Patients with radiographic evidence of bone loss in atleast two teeth.
- Patients who are systematically healthy.
- Patients with localized pockets with probing depth of ≤ 5mm.
- Patients who are cooperative and able to attend the hospital for regular follow-up.
You may not qualify if:
- Patients who have received any surgical or nonsurgical therapy during past 6months
- Pregnant or lactating females.
- Use of systemic antibiotics in the past 6 months.
- Patient who are not willing to give a written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. NALLAGATLA VAMSI VENKATA KRISHNA SAI
Bengaluru, Karnataka, 562157, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2025
First Posted
January 15, 2025
Study Start
January 4, 2024
Primary Completion
August 5, 2024
Study Completion
August 5, 2024
Last Updated
January 15, 2025
Record last verified: 2025-01